GlassScriptPhysician profile
Jonathan G Thomas
NPI 1619207701
$6,576.86
in general payments reported to CMS, 2019-2025
20 companies · $1,642 in 2025
The $1,642 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $294 · 2021: $307 · 2022: $1,265 · 2023: $1,968 · 2024: $980 · 2025: $1,642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,051 · Travel and Lodging: $1,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,050.81 |
| Travel and Lodging | $1,539.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,641.82 | 2021-2025 | Catalyft Pl Expandable Interbody System, Cd Horizon Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Stryker Corporation | $1,388.63 | 2022-2023 | Avs Navigator, Avs Anchor-L, Capri Corpectomy Cage System |
| Alphatec Spine, INC | $611.03 | 2022 | |
| Depuy Synthes Sales INC. | $263.76 | 2019-2021 | |
| Monteris Medical Corporation | $126.95 | 2022 | |
| Medtronic USA, INC. | $117.50 | 2020 | |
| Orthofix Medical, INC. | $82.93 | 2024-2025 | Spinal-Stim |
| Providence Medical Technology, INC. | $77.88 | 2023-2025 | |
| Bard Access Systems, INC. | $39.62 | 2019 | |
| Boston Scientific Corporation | $34.24 | 2022-2025 | General - Pain Management |
| Si-Bone, INC. | $29.96 | 2023 | |
| Ethicon US, LLC | $27.36 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $20.22 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.98 | 2023 | Relistor |
| Aesculap, INC. | $19.73 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $17.68 | 2022 | |
| Puma Biotechnology, INC. | $17.63 | 2019 | |
| Tesaro, INC. | $14.45 | 2019 | |
| Pfizer INC. | $14.32 | 2020 | |
| Integra Lifesciences Corporation | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.